Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial Commentary.
Egan JM, Kibel AS. Egan JM, et al. Among authors: kibel as. Urol Pract. 2024 May;11(3):452. doi: 10.1097/UPJ.0000000000000561. Epub 2024 Mar 7. Urol Pract. 2024. PMID: 38557198 No abstract available.
Editorial Comment.
Stone BV, Kibel AS. Stone BV, et al. Among authors: kibel as. J Urol. 2024 May;211(5):656. doi: 10.1097/JU.0000000000003906. Epub 2024 Mar 14. J Urol. 2024. PMID: 38591700 No abstract available.
Reply by Authors.
Lucas MI, Qian Z, Lipsitz SR, Chen X, Alkhatib K, Kibel AS, Cole AP, Iyer HS, Trinh QD. Lucas MI, et al. Among authors: kibel as. Urol Pract. 2024 Jan;11(1):85. doi: 10.1097/UPJ.0000000000000464.02. Epub 2023 Nov 28. Urol Pract. 2024. PMID: 38048530 No abstract available.
Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries.
Qian Z, Ye J, Friedlander DF, Koelker M, Labban M, Langbein B, Chen CC, Preston MA, Clinton T, Mossanen M, Abdollah F, Lipsitz SR, Kibel AS, Trinh QD, Cole AP. Qian Z, et al. Among authors: kibel as. Can J Urol. 2023 Dec;30(6):11714-11723. Can J Urol. 2023. PMID: 38104328
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.
Yim K, Melnick K, Mott SL, Carvalho FLF, Zafar A, Clinton TN, Mossanen M, Steele GS, Hirsch M, Rizzo N, Wu CL, Mouw KW, Wszolek M, Salari K, Feldman A, Kibel AS, O'Donnell MA, Preston MA. Yim K, et al. Among authors: kibel as. Urol Oncol. 2023 Nov;41(11):458.e1-458.e7. doi: 10.1016/j.urolonc.2023.06.018. Epub 2023 Sep 9. Urol Oncol. 2023. PMID: 37690933
Racial Differences in Germline Genetic Testing for Prostate Cancer: A Systematic Review.
Briggs LG, Steele GL, Qian ZJ, Subbana S, Alkhatib KY, Labban M, Langbein BJ, Nguyen DD, Cellini J, Kilbridge K, Kibel AS, Trinh QD, Rana HQ, Cole AP. Briggs LG, et al. Among authors: kibel as. JCO Oncol Pract. 2023 May;19(5):e784-e793. doi: 10.1200/OP.22.00634. Epub 2023 Jan 12. JCO Oncol Pract. 2023. PMID: 36649495
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.
Tsujino T, Takai T, Hinohara K, Gui F, Tsutsumi T, Bai X, Miao C, Feng C, Gui B, Sztupinszki Z, Simoneau A, Xie N, Fazli L, Dong X, Azuma H, Choudhury AD, Mouw KW, Szallasi Z, Zou L, Kibel AS, Jia L. Tsujino T, et al. Among authors: kibel as. Nat Commun. 2023 Jan 17;14(1):252. doi: 10.1038/s41467-023-35880-y. Nat Commun. 2023. PMID: 36650183 Free PMC article.
Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT & Metabolism Study): Protocol of a longitudinal, observational, cohort study.
Braga-Basaria M, Travison TG, Taplin ME, Lin A, Dufour AB, Habtemariam D, Nguyen PL, Kibel AS, Ravi P, Bearup R, Kackley H, Kafel H, Reid K, Storer T, Simonson DC, McDonnell M, Basaria S. Braga-Basaria M, et al. Among authors: kibel as. PLoS One. 2023 Feb 10;18(2):e0281508. doi: 10.1371/journal.pone.0281508. eCollection 2023. PLoS One. 2023. PMID: 36763576 Free PMC article.
456 results